0 CHECKOUT

PRODUCT FILTERS

REGION

4
3
2
2
2

COUNTRY

2
2
1

CATEGORIES

  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

6
7
8
12

PUBLISHED

0
2
8
12

PRODUCT TYPE

5
5
1
1

Search for: "iNova Pharmaceuticals (Australia) Pty Limited-Company Report"

iNova Pharmaceuticals (Australia) Pty Limited - Strategic SWOT Analysis Review

iNova Pharmaceuticals (Australia) Pty Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The...

Published:  February 2016
Price:  From

Consumer and Market Insights: Suncare in Australia

Summary: The Suncare market in Australia is forecast to register higher growth in value and volume terms during 2015-2020 compared to 2010-2015. Busy lifestyles are driving the demand for easy to...

Published:  March 2016
Price:  From

Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012

Respiratory Tract Inflammatory Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012', provides an overview of...

Published:  November 2012
Price:  From

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

Published:  May 2015
Price:  From

2015 Legal Spend Report by Industry

The 2015 Legal Spend by Industry is the first in-depth and comprehensive analysis of how corporate counsel spends its legal budget by major industry and law firm. Over 80 Industries and Sub-Industries...

Published:  October 2015
Price:  From

Asthma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Asthma Therapeutics in US$ Million The major therapeutic segments analyzed are Inhaled corticosteroids, Short acting beta agonists, Long acting beta agonists,...

Published:  October 2006
Price:  From

Potential Downgrades Hit Highest Year-End Total In Six Years, Says S&P Report Jan 16

Abstract NEW YORK (Standard & Poor's) Jan. 19, 2016--The number of potential downgrades decreased to 655 in December after rising the past six months, the highest year-end total since the 824 potential...

Published:  January 2016
Price: 

Negative Outlooks On Global Corporates Exceed Positive Ones By The Widest Margin Since 2009, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 12, 2016--The net outlook bias is a negative 11%, which is the worst level since the 2008-2009 financial crisis. That's according to a report by Standard...

Published:  January 2016
Price: 

Asia-Pacific And Latin America Amassed Debt At A Far Faster Pace Than Europe And North America, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 14, 2016-Debt growth in Asia-Pacific and Latin America has outstripped the regions' GDP expansion during 2009-2015 at a far faster pace than that in Europe...

Published:  January 2016
Price: 

Global Corporate Debt Demand Declines To $57 Trillion As Credit Risk Concentrates In China, U.S. Jul 15

Abstract MELBOURNE (Standard & Poor's) July 16, 2015--Global corporate debt demand will peak at an estimated $57 trillion by 2019, a decline of 4% from last year's projection, according to an annual...

Published:  July 2015
Price: 

Credit Trends: Potential Bond Rating Upgrades: Pearl Fishing Among Oysters Sep 03

Abstract More entities appear well placed for potential upgrades compared with four months ago, said a report released today from Standard & Poor's Ratings Services, indicating that the trough in this...

Published:  September 2003
Price: 

Aquaporins, Vol 51. Current Topics in Membranes

Aquaporins summarizes the present knowledge in this expanding field of research, starting with the structural analysis of water channel proteins. Subsequent chapters begin with mammalian aquaporins,...

Published:  April 2001
Price:  From
Loading Indicator

Our Clients

  • Walgreen's Company
  • Elanco Global
  • Nu Skin Enterprises
  • Kemin Industries, Inc.
  • Suan Farma Inc.
  • Metagenics, Inc.